Help
RSS
API
Feed
Maltego
Contact
Domain > rejniak.net
×
Welcome!
Right click nodes and scroll the mouse to navigate the graph.
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2015-12-04
82.165.216.239
(
ClassC
)
2024-10-05
74.208.236.185
(
ClassC
)
Port 80
HTTP/1.1 200 OKContent-Type: text/htmlContent-Length: 10655Connection: keep-aliveKeep-Alive: timeout15Date: Sat, 05 Oct 2024 03:24:30 GMTServer: ApacheLast-Modified: Sun, 19 May 2024 01:30:42 GMTETag: 299f-618c488734a0eAccept-Ranges: bytes !DOCTYPE html PUBLIC -//W3C//DTD XHTML 1.0 Transitional//EN http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd>html xmlnshttp://www.w3.org/1999/xhtml>head>meta contenttext/html; charsetUTF-8 http-equivContent-Type />!-- #BeginEditable doctitle -->title>Rejniak Research Lab/title>!-- #EndEditable -->link hrefStylesTemplate1.css relstylesheet typetext/css />style typetext/css>/style>/head>body stylebackground-color: #000000>div idWrapper styleposition: relative; width: 900px; z-index: 2; margin-left: auto; margin-right: auto; background-color: #FFFFFF; left: 0px; top: 0px; height: auto; overflow: auto; float: none> div idMastHead styleposition: relative; width: 900px; height: 200px; z-index: 5; float: left; left: 0px; top: 0px; background-image: url(Images/Template1MastHead.jpg)> div idTextForMastHead classnavbartext styleposition: relative; width: 508px; height: 24px; z-index: 1; float: left; margin-top: 165px; margin-left: 12px; left: 0px; top: 0> a hrefindex.html>Home/a>a hrefresearch.html>~Research/a>a hrefpeople.html>~People/a>a hrefpublications.html>~Publications/a>~a hrefLabsTools.html>Labs/Tools/a>~a hrefnews.html>News/a>/div> div idlayer8 classSiteName styleposition: absolute; width: 524px; height: 52px; z-index: 2; left: 15px; top: 22px>Rejniak Research Lab/div>/div>div idlayer1 styleposition: relative; width: 900px; height: 15px; z-index: 6; float: left; margin-top: 5px; left: 0px; top: 0px;>/div>div idlayer2 styleposition: relative; width: 900px; height: auto; z-index: 7; float: left; background-image: url(Images/line.jpg)> div idLeftColumn styleborder-right: 0; position: relative; width: 300px; height: 60%; z-index: 4; float: left; left: 0px; top: 0px; margin-top: 0> div idlefttext classLeft-Columntxt styleposition: relative; width: 268px; height: auto; z-index: 1; float: left; margin-left: 20px; margin-top: 0; left: 0px; top: 0; margin-bottom: 15px; background-color: #FFFFFF; layer-background-color: #FFFFFF; border: 1px none #000000;> p>span styletext-align: left>Katarzyna (Kasia) Rejniakbr classLeft-Columntxt /> Associate Memberbr classLeft-Columntxt /> a hrefhttp://www.moffitt.org/imo>Integrated Mathematical Oncology/a>br classLeft-Columntxt /> a classauto-style12 hrefhttp://www.moffitt.org target_blank> Moffitt Cancer Center/a>br classLeft-Columntxt /> 12902 Magnolia Drive, Room SRB-4br classLeft-Columntxt /> Tampa, Fl 33612-9416br /> br classLeft-Columntxt /> P: (813) 745-6918br classLeft-Columntxt /> email: Kasia.Rejniak@moffitt.orgbr /> br /> strong>Discipline:/strong> mathematical oncology and computational modeling of cancer micro-pharmacology.br /> br /> strong>Specializations:/strong> bio-mathematics, bio-fluids, bio-mechanics./span>br /> br /> strong>Research Interests (M-10): /strong>/p> ul> li>microenvironment/li> li>mechano-transduction/li> li>morphology/li> li>migration & growth/li> li>metastasis/li> li>metabolism/li> li>microfluids/li> li>machine learning/li> li>multi-scale models/li> li>multi-disciplinary research/li> /ul> /div> /div> !-- #BeginEditable MainContent --> div idRightColumn styleposition: relative; width: 560px; height: auto; z-index: 3; float: right; left: 0px; top: 0; margin-top: 0; margin-right: 20px; margin-left: 20px;> div idlayer7 styleposition: relative; width: 560px; height: auto; z-index: 2; font-style: normal;> h2 aligncenter classaa>strong>em>Computational Micro-Pharmacology Research Lab (CoMPhy Lab)/em>/strong>/h2> p alignjustify classRightParagraph> Our research focuses on mathematical modeling and computational simulations of tumor initiation, progression and treatment. Computational simulations give the unique opportunity for testing various scenarios of tumor emergence and growth, as well as different protocols of chemo-, radio-, immuno-, hormone- and combined therapies. In particular, we are interested in investigating the bio-mechanics of normal vs. tumor-like tissue morphogenesis, micro-fluids in drug delivery and bio-physics of tumor microenvironment using the em>strong>IBCell/strong>/em> model (immersed boundary model of a cell), the em>strong>microPKPD/strong>/em> (regularized Stokeslets method of micro-pharmacodynamics and pharmacokinetics), or the multiscale em>strong>MultiCell/strong>/em>-em>LF/em> (multi-cell lattice-free), em>strong>silicoDCIS,/strong>/em> and em>strong>Organoid3D/strong>/em> models. /p> br> h2 aligncenter classaa> p stylecolor:red;>~~Multiple Research Positions Available~~/p>/h2> h3 aligncenter> More information can be found a hrefRejniakLab_jobs.html>here/a> /h3>. ul> li>in the media: a hrefhttps://thisweekmathonco.substack.com/p/this-week-in-mathonco-287>This Week in Math Oncology features our HAPs paper/a>/li> li>in the media: a hrefhttps://thisweekmathonco.substack.com/p/this-week-in-mathonco-279>This Week in Math Oncology features our cell-ECM paper/a>/li> li>in the media: a hrefhttps://thisweekmathonco.substack.com/p/this-week-in-mathonco-175>This Week in Math Oncology features our O2 fluctuation paper/a>/li> li>in the media: a hrefhttps://www.advancedsciencenews.com/hybrid-modeling-to-address-cancer-complexity/>Advanced Science News featured our Hybrid Modeling review/a>/li> li>in the media: a hrefhttps://www.youtube.com/watch?time_continue23&vwk4oemVKxgQ>Shreya and Shannon about the HIP-IMO program (YouTube)/a>/li> li>in the media: a hrefSpotlightInterview.html>MRI Spotlight Interview with Kasia Rejniak/a>/li> li>in the media: a hrefTheMedicineMaker.html>The Medicine Maker featured our Sci Reports paper/a>/li> li>in the media: a hrefhttps://moffitt.org/newsroom/press-release-archive/2018/moffitt-researchers-use-single-cell-imaging-and-mathematical-modeling-to-determine-effective-drug-properties/>Single-cell modeling & imaging for targeted drugs (Moffitt PR)/a>/li> li>in the media: a hrefhttp://atlasofscience.org/virtuoso/>Atlas of Science features our Virtual Clinical Trials paper/a>/li> li>in the media: a hrefInternationalInnovations.html>Crunching cancer with digital drugs (p.28-30)/a>/li> li>in the media: a hrefhttps://moffitt.org/newsroom/press-release-archive/2014/mathematical-modeling-offers-a-new-approach-to-cancer-treatment-moffitt-cancer-center-researchers-say/>Modeling the penetration of anti-cancer drugs (Moffitt PR)/a>/li> li>in the media:a hrefhttps://www.facebook.com/photo.php?fbid571386852942196&setpb.210971462317072.-2207520000.1384009361.&type3&theater> Miles for Moffitt Award and the pharmaco-mechanics project/a>/li> li>in the media: a hrefhttps://globalmedicaldiscovery.com/key-scientific-articles/formation-tight-tumor-clusters-affects-efficacy-cell-cycle-inhibitors-hybrid-model-study/>Global Medical Discovery features our CDK inhibitors paper/a>/li> /ul> table width524 border0 aligncenter> tr> td styletext-align: center>We are/were funded by:/td> /tr> tr> td styletext-align: center>strong>NIH/NCI R01 grant with Damaghi lab/strong>/td> /tr> tr> td styletext-align: center>a hrefImages/Signals_2022_DoD.png> strong>DoD Team Award grant with Pilon-Thomas and Poch lab/strong>/a>/td> /tr> tr> td styletext-align: center>a hrefImages/Signals_2021_R01.png> strong>NIH/NCI R01 grant with Pilon-Thomas lab/strong>/a>/td> /tr> tr> td styletext-align: center>strong> a hrefhttps://physics.cancer.gov/research-funding/vanderbilt>NIH/NCI Physical Science-Oncology Projects (Vanderbilt-Moffitt U01)/a>/strong>/td> /tr> tr> td styletext-align: center>strong>Moffitt Team Science Award/strong>/td> /tr> tr> td styletext-align: center>strong>a hrefhttps://moffitt.org/research-science/centers-and-institutes/centers-of-excellence/center-for-immunization-and-infection-research-in-cancer/>Moffitt CIIRC Award/a>/strong>/td> /tr> tr> td width518 styletext-align: center>strong>a hrefhttp://www.floridahealth.gov/provider-and-partner-resources/research/funding-opportunity-announcements/coleyfoa.html>Bankhead Coley Bridge Award/a>/strong>/td> /tr> tr> td styletext-align: center>strong>a hrefhttp://icbp.nci.nih.gov/>NIH/NCI Integrative Cancer Biology Program (Vanderbilt-Moffitt ICBP)/a>/strong>/td> /tr> tr> td styletext-align: center>strong>a hrefhttp://physics.cancer.gov/>NIH/NCI Physical Science-Oncology Center Program (Moffitt PSOC)/a>/strong>/td> /tr> tr> td styletext-align: center>strong>a hrefhttp://www.milesformoffitt.com/>Miles for Moffitt Milestones Research Award/a>/strong>/td> /tr> tr> td styletext-align: center>strong>a hrefhttp://www.cancer.org/research/index>American Cancer Society-Institutional Research Grant/a>/strong>/td> /tr> tr> td styletext-align: center>a hrefhttp://www.moffitt.org/imo>img srcImages/IMOlogo.jpg width283 height41 altIMO />/a>/td> /tr> /table> p> /p> p> /p> p> /p> p> /p> p> /p> p alignjustify classRightParagraph> /p> /div> br /> /div>!-- #EndEditable -->/div>div idlayer3 styleposition: relative; width: 900px; height: 20px; z-index: 8; left: 0px; top: 0px; float: left> /div>/div>div idFooter styleposition: relative; width: 900px; height: 200px; z-index: 1; margin-left: auto; margin-right: auto; background-image: url(Images/secondschabathfooter.jpg)>div idfootertext styleposition: relative; width: auto; height: 20px; z-index: 2; float: left; margin-top: 132px; margin-left: 50px; left: 0; top: 0px classFootertext> a hrefindex.html>Home/a> a hrefresearch.html>Research/a> a hrefpeople.html> People/a> a hrefpublications.html>Publications/a> a hrefLabsTools.html>Labs/Tools /a>a hrefnews.html>News/a>/div>/div>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]